FDA Reviews Zoryve Cream for Eczema in Babies as Young as 3 Months
The FDA accepted Arcutis' application for Zoryve (roflumilast) cream in infants 3 months and up with eczema. A decision is expected in early 2027, with nearly half of infants clearing by week four.